Protalix BioTherapeutics (PLX) Receivables - Other (2010 - 2019)
Protalix BioTherapeutics (PLX) posted quarterly Receivables - Other of $26000.0 for Q4 2019, down 99.0% quarter-over-quarter from $2.6 million in Q1 2014.
Protalix BioTherapeutics (PLX) Receivables - Other (2010 - 2019) Analysis & Trends
Protalix BioTherapeutics' Receivables - Other history runs 6 years deep, the most recent figure standing at $26000.0 for Q4 2019.
- In Q4 2019, Receivables - Other changed N/A year-over-year to $26000.0; the TTM figure through Dec 2019 stood at $26000.0 (changed N/A YoY), while the FY2019 annual figure was $26000.0, changed N/A from the prior year.
- Receivables - Other for Q4 2019 stood at $26000.0, down from $2.6 million in the prior quarter.
- The five-year high for Receivables - Other was $26000.0 in Q4 2019, with the low at $26000.0 in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Protalix BioTherapeutics | 190.37 Mn | 149.71 Mn | 12.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 26,000.00 |
| Dec 31, 2019 | 26,000.00 |
| Mar 31, 2014 | 2.61 Mn |
| Mar 31, 2014 | 2.61 Mn |
| Dec 31, 2013 | 1.46 Mn |
| Dec 31, 2013 | 1.46 Mn |
| Sep 30, 2013 | 4.17 Mn |
| Sep 30, 2013 | 4.17 Mn |
| Jun 30, 2013 | 3.59 Mn |
| Jun 30, 2013 | 3.59 Mn |
| Mar 31, 2013 | 3.55 Mn |
| Mar 31, 2013 | 3.55 Mn |
| Dec 31, 2012 | 3.69 Mn |
| Dec 31, 2012 | 3.69 Mn |
| Sep 30, 2012 | 3.28 Mn |
| Sep 30, 2012 | 3.28 Mn |
| Jun 30, 2012 | 4.05 Mn |
| Jun 30, 2012 | 4.05 Mn |
| Mar 31, 2012 | 3.15 Mn |
| Mar 31, 2012 | 3.15 Mn |